Fanconi Anemia, Complementation Group L (FANCL) Peptide
Aperçu rapide pour Fanconi Anemia, Complementation Group L (FANCL) Peptide (ABIN936892)
Antigène
Origine
Source
Application
-
-
Type de proteíne
- Synthetic
-
Séquence
- ASGREHLITL KLKAKYPAES PDYFVDFPVP FCASWTPQVN SPQSSLISIY
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of FANCL antibody,
Alternative Names: FANCL control peptide, FANCL antibody Blocking Peptide, Anti-FANCL Blocking Peptide, Fanconi Anemia Complementation Group L Blocking Peptide, FAAP43 Blocking Peptide, FLJ10335 Blocking Peptide, PHF9 Blocking Peptide, POG Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
-
Sujet
- The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM and FANCN. The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.
-
Poids moléculaire
- 42 kDa
Antigène
-